Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.

Also called NCT03696940

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Laboratorios Grossman, S.A. (from the registry)
Registry
  • NCT NCT03696940
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03696940. Randomized; single masking; primary purpose treatment. Start 2018-05-28 (actual); primary completion 2019-03-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
Condition
Dyslipidemias
Condition
Cardiovascular Risk Factor
Intervention (Drug)
L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg
Intervention (Drug)
Atorvastatin 10mg
Lead sponsor
Laboratorios Grossman, S.A. (class: industry)
Collaborator
Instituto Nacional de Salud Publica, Mexico (class: other)

Record details

Record id
cardio:ct-nct03696940
Content hash
9f92022f26267139525ede7716132152b310332bba1b1b6ba97b7505354c3b16